94 related articles for article (PubMed ID: 155127)
1. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
Highsmith RF; Burnett CJ; Weirich CJ
J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
[No Abstract] [Full Text] [Related]
2. Protease inhibitors of human plasma. C1-inhibitor (C1-INH).
Prograis LJ; Brickman CM; Frank MM
J Med; 1985; 16(1-3):303-50. PubMed ID: 3915997
[No Abstract] [Full Text] [Related]
3. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
[TBL] [Abstract][Full Text] [Related]
4. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.
Donaldson VH; Rosen FS; Bing DH
Trans Assoc Am Physicians; 1977; 90():174-83. PubMed ID: 148134
[No Abstract] [Full Text] [Related]
5. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
7. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
Donaldson VH; Harrison RA
Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
[No Abstract] [Full Text] [Related]
8. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
Urano T; Sumiyoshi K; Pietraszek MH; Takada Y; Takada A
Thromb Haemost; 1991 Oct; 66(4):474-8. PubMed ID: 1796399
[TBL] [Abstract][Full Text] [Related]
9. [Episodes of angioedema in children with C1 esterase inhibitor deficiency].
Strengers PF
Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1480; author reply 1481. PubMed ID: 16875273
[No Abstract] [Full Text] [Related]
10. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
11. Generation of plasmin during acute attacks of hereditary angioedema.
Cugno M; Hack CE; de Boer JP; Eerenberg AJ; Agostoni A; Cicardi M
J Lab Clin Med; 1993 Jan; 121(1):38-43. PubMed ID: 8426080
[TBL] [Abstract][Full Text] [Related]
12. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
Brown EW; Ravindran S; Patston PA
Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
[TBL] [Abstract][Full Text] [Related]
13. A method using fibrin-fixed Blue Dextran for determining the plasmin and plasmin inhibitor activities in human plasma.
Tamura Y; Otsuka A; Sone K; Sakurai E; Mori H; Sumi H; Kosugi T; Fujii S
Biochim Biophys Acta; 1978 Jul; 525(1):194-9. PubMed ID: 150858
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
Kluft C
Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
[TBL] [Abstract][Full Text] [Related]
15. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
Kluft C
Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
[TBL] [Abstract][Full Text] [Related]
16. The C1 inhibitor deficiency. A review.
Carreer FM
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):793-807. PubMed ID: 1489854
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
Binnema DJ; Dooijewaard G; Turion PN
Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
[TBL] [Abstract][Full Text] [Related]
18. Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic system.
Moriyama T; Suzuki S; Matsuno K; Okada K; Matsuo O
Semin Thromb Hemost; 2002 Dec; 28(6):529-32. PubMed ID: 12536345
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
20. Plasma inhibitors of the components of the fibrinolytic pathway in man.
Schreiber AD; Kaplan AP; Austen KF
J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
